Quantinno Capital Management LP Purchases 4,838 Shares of Universal Health Services, Inc. $UHS

Quantinno Capital Management LP raised its holdings in shares of Universal Health Services, Inc. (NYSE:UHS) by 1.5% during the first quarter, according to its most recent filing with the SEC. The firm owned 330,848 shares of the health services provider’s stock after purchasing an additional 4,838 shares during the period. Quantinno Capital Management LP’s holdings in Universal Health Services were worth $59,212,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of UHS. Elyxium Wealth LLC bought a new stake in Universal Health Services during the fourth quarter valued at about $25,000. Harbor Capital Advisors Inc. bought a new position in Universal Health Services in the fourth quarter worth about $26,000. Founders Capital Management bought a new position in Universal Health Services in the fourth quarter worth about $28,000. CYBER HORNET ETFs LLC purchased a new stake in shares of Universal Health Services during the second quarter valued at about $29,000. Finally, Larson Financial Group LLC lifted its position in shares of Universal Health Services by 302.9% during the fourth quarter. Larson Financial Group LLC now owns 141 shares of the health services provider’s stock valued at $31,000 after buying an additional 106 shares during the last quarter. Institutional investors own 86.05% of the company’s stock.

Universal Health Services News Summary

Here are the key news stories impacting Universal Health Services this week:

• Positive Sentiment: Q2 earnings beat expectations: UHS reported adjusted earnings of $5.98 per share versus the $5.94 consensus estimate, while revenue reached $4.64 billion, ahead of the $4.58 billion forecast. Revenue increased 8.3% year over year, helped by growth in both Acute Care and Behavioral Health. UHS Beats Q2 Earnings and Revenue Estimates Despite Cost Pressures
• Positive Sentiment: Strong cash-flow and capital-return outlook: Management forecasts 2026 adjusted EBITDA less noncontrolling interests of $2.61 billion to $2.72 billion and plans to remain “highly active” in share buybacks. Repurchases could support earnings per share and provide demand for the stock. UHS Forecasts 2026 EBITDA and Plans Buybacks
• Positive Sentiment: Outpatient expansion opportunity: UHS views its Talkspace relationship as an accelerant for outpatient growth, potentially broadening access to behavioral-health services and supporting longer-term growth. Why UHS Sees Talkspace as an Accelerant for Outpatient Growth
• Neutral Sentiment: Mixed analyst signals: Cantor Fitzgerald reaffirmed a Neutral rating but raised or maintained a $194 price target, implying meaningful potential upside, while Barclays cut its target to $168 and retained an Equal Weight rating. Analyst Ratings
• Negative Sentiment: Additional target reduction: Robert W. Baird lowered its price target from $204 to $166 and assigned a Neutral rating, indicating limited near-term upside based on its revised valuation. Baird Lowers UHS Price Target
• Negative Sentiment: Cost pressures remain a concern: Higher operating costs weighed on quarterly performance, tempering the positive impact of revenue growth and the earnings beat.

Universal Health Services Price Performance

NYSE:UHS opened at $168.32 on Thursday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.12 and a quick ratio of 1.01. The company has a 50 day moving average price of $150.47 and a 200-day moving average price of $178.51. Universal Health Services, Inc. has a 1-year low of $140.08 and a 1-year high of $246.32. The firm has a market cap of $10.19 billion, a price-to-earnings ratio of 6.86, a price-to-earnings-growth ratio of 0.90 and a beta of 1.07.

Universal Health Services (NYSE:UHS) last released its quarterly earnings results on Monday, July 27th. The health services provider reported $5.98 EPS for the quarter, beating the consensus estimate of $5.94 by $0.04. Universal Health Services had a net margin of 8.42% and a return on equity of 19.39%. The company had revenue of $4.64 billion for the quarter, compared to analyst estimates of $4.58 billion. During the same quarter last year, the business earned $5.35 earnings per share. The firm’s revenue was up 8.3% on a year-over-year basis. Universal Health Services has set its FY 2026 guidance at 22.280-23.650 EPS. Equities research analysts forecast that Universal Health Services, Inc. will post 23.16 EPS for the current year.

Universal Health Services Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Tuesday, September 1st. Universal Health Services’s dividend payout ratio (DPR) is 3.33%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Robert W. Baird lowered their price objective on Universal Health Services from $204.00 to $166.00 and set a “neutral” rating for the company in a research report on Wednesday. Stephens reduced their target price on Universal Health Services from $235.00 to $205.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 29th. TD Cowen decreased their price target on Universal Health Services from $230.00 to $197.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Barclays lowered their price target on Universal Health Services from $179.00 to $168.00 and set an “equal weight” rating for the company in a report on Tuesday. Finally, Raymond James Financial downgraded shares of Universal Health Services from an “outperform” rating to a “market perform” rating in a report on Wednesday, April 29th. Five research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $207.33.

Universal Health Services Profile

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.